Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edna Mozes

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2003
A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cellsMiri Paas-Rozner, Michael Sela, Edna Mozes
Journal of Neuroimmunology|June 8, 2006
Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4+ CD25+ regulatory cellsBadiga Venkata Aruna, Michael Sela, Edna Mozes
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2005
Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cellsBadiga Venkata Aruna, Michael Sela, Edna Mozes
Journal of Clinical Immunology|September 17, 2009
A new model of induced experimental systemic lupus erythematosus (SLE) in pigs and its amelioration by treatment with a tolerogenic peptideAmir Sharabi, Molly Dayan, Heidy Zinger, et al.
International Immunology|February 13, 2003
Peptides based on the complementarity-determining regions of a pathogenic autoantibody mitigate lupus manifestations of (NZB x NZW)F1 mice via active suppressionHeidy Zinger, Eran Eilat, Asher Meshorer, et al.
European Journal of Immunology|September 15, 2022
Prof. Michael Sela (1924-2022)Ruth Arnon, Edna Mozes, Steffen Jung, et al.
Immunology|March 10, 2007
Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of actionAmir Sharabi, Hava Azulai, Zev M Sthoeger, et al.
Clinical Immunology (Orlando, Fla.)|December 17, 2002
A peptide based on an anti-DNA autoantibody downregulates matrix metalloproteinases in murine models of lupusAnat Faber-Elmann, Eran Eilat, Heidy Zinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
A peptide that ameliorates lupus up-regulates the diminished expression of early growth response factors 2 and 3Uri Sela, Molly Dayan, Rami Hershkoviz, et al.
Clinical Immunology (Orlando, Fla.)|March 1, 2006
Amelioration of murine lupus by a peptide, based on the complementarity determining region-1 of an autoantibody as compared to dexamethasone: different effects on cytokines and apoptosisAmir Sharabi, Asher Haviv, Heidy Zinger, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2003
A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cellsMiri Paas-Rozner, Michael Sela, Edna Mozes
Journal of Neuroimmunology|June 8, 2006
Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4+ CD25+ regulatory cellsBadiga Venkata Aruna, Michael Sela, Edna Mozes
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2005
Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cellsBadiga Venkata Aruna, Michael Sela, Edna Mozes
Journal of Clinical Immunology|September 17, 2009
A new model of induced experimental systemic lupus erythematosus (SLE) in pigs and its amelioration by treatment with a tolerogenic peptideAmir Sharabi, Molly Dayan, Heidy Zinger, et al.
International Immunology|February 13, 2003
Peptides based on the complementarity-determining regions of a pathogenic autoantibody mitigate lupus manifestations of (NZB x NZW)F1 mice via active suppressionHeidy Zinger, Eran Eilat, Asher Meshorer, et al.
European Journal of Immunology|September 15, 2022
Prof. Michael Sela (1924-2022)Ruth Arnon, Edna Mozes, Steffen Jung, et al.
Immunology|March 10, 2007
Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of actionAmir Sharabi, Hava Azulai, Zev M Sthoeger, et al.
Clinical Immunology (Orlando, Fla.)|December 17, 2002
A peptide based on an anti-DNA autoantibody downregulates matrix metalloproteinases in murine models of lupusAnat Faber-Elmann, Eran Eilat, Heidy Zinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
A peptide that ameliorates lupus up-regulates the diminished expression of early growth response factors 2 and 3Uri Sela, Molly Dayan, Rami Hershkoviz, et al.
Clinical Immunology (Orlando, Fla.)|March 1, 2006
Amelioration of murine lupus by a peptide, based on the complementarity determining region-1 of an autoantibody as compared to dexamethasone: different effects on cytokines and apoptosisAmir Sharabi, Asher Haviv, Heidy Zinger, et al.
Pageof 6